Additionally, GF9 significantly decreases serum levels of macrophage colony-stimulating factor (M-CSF or CSF-1), a key factor promoting tumor growth and metastasis, indicating its potential anticancer properties via M-CSF suppression. This evidence concerns the gene CSF1 and neoplasm.